The Oncogenic MicroRNA miR-22 Targets the TET2 Tumor Suppressor to Promote Hematopoietic Stem Cell Self-Renewal and Transformation
Authors:
- Ugo AlaUAUgo Ala
- Lev KatsLKLev Kats
- Kaitlyn WebsterKWKaitlyn Webster
- Mojca Jongen-LavrencicMJMojca Jongen-Lavrencic
- Pier Paolo PandolfiPier Paolo Pandolfi
- 1 July 2013
- journal article
- research article
- Published by Elsevier in Cell Stem Cell
- Vol. 13 (1) , 87-101
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- The role of mutations in epigenetic regulators in myeloid malignanciesNature Reviews Cancer, 2012
- A continuum model for tumour suppressionNature, 2011
- Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid TransformationCancer Cell, 2011
- Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2Nature, 2010
- Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndromeEuropean Journal of Human Genetics, 2010
- Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specificationNature, 2010
- Mutation inTET2in Myeloid CancersNew England Journal of Medicine, 2009
- The microRNA.org resource: targets and expressionNucleic Acids Research, 2007
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA TargetsCell, 2005